Document Detail


Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility.
MedLine Citation:
PMID:  12196666     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The fetal valproate syndrome (FVS) is characterized by distinctive facial appearance, major and minor malformations, and developmental delay. Generally, only a small proportion of prenatally exposed children are affected. The authors describe three families in whom the occurrence of FVS in all the siblings strongly suggests hereditary susceptibility to valproic acid-induced adverse outcome. The risk for recurrence in a subsequent pregnancy may be high and should be taken into account in the counseling of parents and in considering drug treatment.
Authors:
H Malm; E Kajantie; S Kivirikko; H Kääriäinen; M Peippo; M Somer
Related Documents :
20477226 - Asthma and pregnancy: a review of two decades.
8081646 - Epilepsy, pregnancy and parenting--an american perspective.
10724046 - The effects of immunosuppressive and anti-inflammatory medications on fertility, pregna...
936986 - A prospective study of drugs and pregnancy. 3. hormones.
15027666 - Advances in preconception genetic counseling.
258266 - The relationship between previous elective abortions and postpartum depressive reactions.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Neurology     Volume:  59     ISSN:  0028-3878     ISO Abbreviation:  Neurology     Publication Date:  2002 Aug 
Date Detail:
Created Date:  2002-08-28     Completed Date:  2002-09-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  630-3     Citation Subset:  AIM; IM    
Affiliation:
Teratology Information Service, Department of Medical Genetics, Family Federation of Finland, Helsinki.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Drug-Induced* / diagnosis
Abnormalities, Multiple / chemically induced*,  diagnosis
Child
Child, Preschool
Developmental Disabilities / chemically induced*,  diagnosis
Epilepsy / drug therapy
Face / abnormalities*
Female
Genetic Predisposition to Disease*
Humans
Infant
Infant, Newborn
Male
Maternal-Fetal Exchange
Pregnancy
Pregnancy Complications / drug therapy
Syndrome
Valproic Acid / adverse effects*
Chemical
Reg. No./Substance:
99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects.
Next Document:  Temporal lobectomy for epilepsy: recovery of the contralateral hippocampus measured by (1)H MRS.